MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China

BMC Neuroscience

Volumn 15, Issue , 2014, Pages

  Yu, Lan ^a   Huang, Jinsha ^a   Zhai, Desheng ^c   Liu, Ling ^a   Guo, Kexin ^a   Long, Xi ^a   Xiong, Jing ^b   Zhang, Zhentao ^b   Wang, Youpei ^a   Zhao, Ying ^c   Wu, Ping ^d   Wang, Dingan ^d   Lin, Zhicheng ^e,f,g   Wu, Jing ^a   Xiong, Nian ^a   Wang, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c XINXIANG MEDICAL UNIVERSITY   (China)

^d Hefeng Central Hospital Hefeng   (China)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MCLEAN HOSPITAL   (United States)

^g The Harvard Center for Neurodegeneration & Repair   (United States)

Author keywords

Genetic risk factor; GSK3 ; MAPT H1 haplotype; Parkinson's disease

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN; GENETIC MARKER; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MAPT PROTEIN, HUMAN;

ADULT; ARTICLE; CHINA; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT;

CHINA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT; TAU PROTEINS;

EID: 84899981392     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-15-54     Document Type: Article

References (22)

1. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996, 55(3):259-272. 10.1097/00005072-199603000-00001, 8786384.
2. Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007, 8(9):663-672.
3. Kalinderi K, Fidani L, Katsarou Z, Clarimon J, Bostantjopoulou S, Kotsis A. GSK3beta polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort. Neurobiol Aging 2011, 32(3):546. e541-545.
4. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999, 8(4):711-715. 10.1093/hmg/8.4.711, 10072441.
5. Fidani L, Kalinderi K, Bostantjopoulou S, Clarimon J, Goulas A, Katsarou Z, Hardy J, Kotsis A. Association of the Tau haplotype with Parkinson's disease in the Greek population. Mov Disord 2006, 21(7):1036-1039. 10.1002/mds.20864, 16552760.
6. Refenes N, Bolbrinker J, Tagaris G, Orlacchio A, Drakoulis N, Kreutz R. Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease. BMC Neurol 2009, 9:26. 10.1186/1471-2377-9-26, 2709887, 19558713.
7. Skipper L, Wilkes K, Toft M, Baker M, Lincoln S, Hulihan M, Ross OA, Hutton M, Aasly J, Farrer M. Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am J Hum Genet 2004, 75(4):669-677. 10.1086/424492, 1182054, 15297935.
8. Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle, Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 1980, 107(2):519-527.
9. Rankin CA, Sun Q, Gamblin TC. Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol Neurodegener 2007, 2:12. 10.1186/1750-1326-2-12, 1936422, 17598919.
10. Kwok JB, Hallupp M, Loy CT, Chan DK, Woo J, Mellick GD, Buchanan DD, Silburn PA, Halliday GM, Schofield PR. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann Neurol 2005, 58(6):829-839. 10.1002/ana.20691, 16315267.
11. Wider C, Vilarino-Guell C, Heckman MG, Jasinska-Myga B, Ortolaza-Soto AI, Diehl NN, Crook JE, Cobb SA, Bacon JA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study. Eur J Neurol 2011, 18(6):876-881. 10.1111/j.1468-1331.2010.03297.x, 21159074.
12. Yuan Y, Tong Q, Zhou X, Zhang R, Qi Z, Zhang K. The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: a meta-analysis. Gene 2013, 524(2):133-138. 10.1016/j.gene.2013.04.045, 23628795.
13. Guedj M, Nuel G, Prum B. A note on allelic tests in case-control association studies. Ann Hum Genet 2008, 72(Pt 3):407-409.
14. Faul F, Erdfelder E, Lang AG, Buchner A. G Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39(2):175-191. 10.3758/BF03193146, 17695343.
15. Evans W, Fung HC, Steele J, Eerola J, Tienari P, Pittman A, Silva R, Myers A, Vrieze FW, Singleton A, Hardy J. The tau H2 haplotype is almost exclusively Caucasian in origin. Neurosci Lett 2004, 369(3):183-185. 10.1016/j.neulet.2004.05.119, 15464261.
16. Zhang J, Song Y, Chen H, Fan D. The tau gene haplotype h1 confers a susceptibility to Parkinson's disease. Eur Neurol 2005, 53(1):15-21. 10.1159/000082956, 15627775.
17. Healy DG, Abou-Sleiman PM, Lees AJ, Casas JP, Quinn N, Bhatia K, Hingorani AD, Wood NW. Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry 2004, 75(7):962-965. 10.1136/jnnp.2003.026203, 1739086, 15201350.
18. Landrigan PJ, Sonawane B, Butler RN, Trasande L, Callan R, Droller D. Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect 2005, 113(9):1230-1233. 10.1289/ehp.7571, 1280407, 16140633.
19. Winkler S, Konig IR, Lohmann-Hedrich K, Vieregge P, Kostic V, Klein C. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease. Eur J Hum Genet 2007, 15(11):1163-1168. 10.1038/sj.ejhg.5201901, 17637803.
20. Das G, Misra AK, Das SK, Ray K, Ray J. Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: A study from India. Neurobiol Aging 2012, 33(7):1485. e9-15.
21. Garcia-Gorostiaga I, Sanchez-Juan P, Mateo I, Rodriguez-Rodriguez E, Sanchez-Quintana C, del Olmo SC, Vazquez-Higuera JL, Berciano J, Combarros O, Infante J. Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases. Ann Neurol 2009, 65(6):759-761. author reply 761-752.
22. Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C. Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience 2005, 132(3):581-589. 10.1016/j.neuroscience.2004.12.029, 15837120.